PTGS2 and neoplasm: As a matter of fact, tumor-derived EVs deliver surface signals that modulate the expression of immunoregulatory genes, such as cyclooxygenase 2 (COX2), interleukin (IL)-10, CD39, CD73, programmed death-ligand (PDL)-1, and CD26, which suppress regulatory T cells (Treg cells) [59].